ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder. ResMed makes continuous positive ...
The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...
Sleep tradingapnea, a condition that involves pauses in breathing during sleep, may be behind this, thus causing hindered ...
According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...
Pune, Jan. 21, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Sleep Apnea Devices Market size was valued at USD 5.25 billion in 2023 and is expected to reach USD 9.43 billion by 2032 ...
Obstructive sleep apnea (OSA) is very common with 15% to 30% of men in the United States and 10% to 15% of women having the ...
When most people think about sleep apnea, I’d assume they think of snoring. Snoring is just one type of sleep apnea that most ...
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
The great quarter was driven by high demand for sleep-related products and growth in digital health solutions. As a specialist in sleep and respiratory health, ResMed built its reputation through ...
On today’s CT BUZZ, Host Natasha Lubczenko sat down with Dr. Zach Korwin, owner of Sleep Stratford, to discuss an innovative ...
The Vietnam Sleep Apnea Devices Market Report provides an insightful analysis of the current landscape and future prospects of sleep apnea devices within the Vietnamese market. This report aims to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback